Abstract
Selecting for antibodies against specific cell-surface proteins is a difficult task due to many unrelated proteins that are expressed on the cell surface. Here, we describe a method to screen antibody-presenting phage libraries against native cell-surface proteins. We applied this method to isolate antibodies that selectively recognize CCR5, which is the major co-receptor for HIV entry (consequently, playing a pivotal role in HIV transmission and pathogenesis). We employed a phage screening strategy by using cells that co-express GFP and CCR5, along with an excess of control cells that do not express these proteins (and are otherwise identical to the CCR5-expressing cells). These control cells are intended to remove most of the phages that bind the cells nonspecifically; thus leading to an enrichment of the phages presenting anti-CCR5-specific antibodies. Subsequently, the CCR5-presenting cells were quantitatively sorted by flow cytometry, and the bound phages were eluted, amplified, and used for further successive selection rounds. Several different clones of human single-chain Fv antibodies that interact with CCR5-expressing cells were identified. The most specific monoclonal antibody was converted to a full-length IgG and bound the second extracellular loop of CCR5. The experimental approach presented herein for screening for CCR5-specific antibodies can be applicable to screen antibody-presenting phage libraries against any cell-surface expressed protein of interest.
Original language | English |
---|---|
Pages (from-to) | 277-290 |
Number of pages | 14 |
Journal | Viral Immunology |
Volume | 26 |
Issue number | 4 |
DOIs | |
State | Published - 1 Aug 2013 |
All Science Journal Classification (ASJC) codes
- Molecular Medicine
- Virology
- Immunology
Access to Document
Other files and links
Fingerprint
Dive into the research topics of 'The isolation of novel phage display-derived human recombinant antibodies against CCR5, the major co-receptor of HIV'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: Viral Immunology, Vol. 26, No. 4, 01.08.2013, p. 277-290.
Research output: Contribution to journal › Article › peer-review
TY - JOUR
T1 - The isolation of novel phage display-derived human recombinant antibodies against CCR5, the major co-receptor of HIV
AU - Shimoni, Moria
AU - Herschhorn, Alon
AU - Britan-Rosich, Yelena
AU - Kotler, Moshe
AU - Benhar, Itai
AU - Hizi, Amnon
N1 - Cited By :3 Export Date: 14 July 2022 CODEN: VIIME Correspondence Address: Hizi, A.; Department of Cell and Developmental Biology, Sackler School of Medicine, Tel Aviv University, Tel Aviv 69978, Israel; email: [email protected] Chemicals/CAS: single chain fragment variable antibody, 334577-34-3, 334577-38-7 References: Alkhatib, G., Combadiere, C., Broder, C.C., Feng, Y., Kennedy, P.E., Murphy, P.M., Berger, E.A., CC ckr5: A rantes, mip-1alpha, mip-1beta receptor as a fusion cofactor for macrophage-tropic hiv-1 (1996) Science, 272, pp. 1955-1958; Atchison, R.E., Gosling, J., Monteclaro, F.S., Franci, C., Digilio, L., Charo, I.F., Goldsmith, M.A., Multiple extracellular elements of ccr5 and hiv-1 entry: Dissociation from response to chemokines (1996) Science, 274, pp. 1924-1926; Babcock, G.J., Mirzabekov, T., Wojtowicz, W., Sodroski, J., Ligand binding characteristics of cxcr4 incorporated into paramagnetic proteoliposomes (2001) J Biol Chem, 276, pp. 38433-38440; Barbas, C.F., Burton, D.R., Scott, K.J., Silverman, G.J., (2001) Phage Display: A Laboratory Manual, , Cold Spring Harbor Laboratory Press, New York; Becerril, B., Poul, M.A., Marks, J.D., Toward selection of internalizing antibodies from phage libraries (1999) Biochem Biophys Res Commun, 55, pp. 386-393; Bernstone, L., Van Wilgenburg, B., James, W., Several commercially available anti-CCR5 monoclonal antibodies lack specificity and should be used with caution (2012) Hybridoma, 31, pp. 7-19; Blanpain, C., Vanderwinden, J.M., Cihak, J., Multiple active states and oligomerization of CCR5 revealed by functional properties of monoclonal antibodies (2002) Mol Biol Cell, 13, pp. 723-737; Boel, E., Bootsma, H., De Kruif, J., Phage antibodies obtained by competitive selection on complement-resistant Moraxella (Branhamella) catarrhalis recognize the high-molecular-weight outer membrane protein (1998) Infect Immun, 66, pp. 83-88; Bradbury, A., Persic, L., Werge, T., Cattaneo, A., Use of living columns to select specific phage antibodies (1993) Biotechnology, 11, pp. 1565-1569; Cai, X., Garen, A., Anti-melanoma antibodies from melanoma patients immunized with genetically modified autologous tumor cells: Selection of specific antibodies from single-chain Fv fusion phage libraries (1995) Proc Natl Acad Sci USA, 92, pp. 6537-6541; Chamow, S.M., Ashkenazi, A., Immunoadhesins: Principles and applications (1996) Trends Biotechnol, 14, pp. 52-60; Clackson, T., Hoogenboom, H.R., Griffiths, A.D., Winter, G., Making antibody fragments using phage display libraries (1991) Nature, 352, pp. 624-628; Coakley, E., Petropoulos, C.J., Whitcomb, J.M., Assessing chemokine co-receptor usage in HIV (2005) Curr Opin Infect Dis, 18, pp. 9-15; Deng, H., Liu, R., Ellmeier, W., Identification of a major co-receptor for primary isolates of HIV-1 (1996) Nature, 381, pp. 661-666; Deng, H.K., Unutmaz, D., Kewalramani, V.N., Littman, D.R., Expression cloning of new receptors used by simian and human immunodeficiency viruses (1997) Nature, 388, pp. 296-300; Dragic, T., Litwin, V., Allaway, G.P., HIV-1 entry into CD4 + cells is mediated by the chemokine receptor CC-CKR (1996) Nature, 381, pp. 667-673; Dubridge, R.B., Tang, P., Hsia, H.C., Leong, P.M., Miller, J.H., Calos, M.P., Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system (1987) Mol Cell Biol, 7, pp. 379-387; Eckert, D.M., Kim, P.S., Mechanisms of viral membrane fusion its inhibition (2001) Annu Rev Biochem, 70, pp. 777-810; Farzan, M., Mirzabekov, T., Kolchinsky, P., Tyrosine sulfation of the amino terminus of CCR5 facilitates HIV-1 entry (1999) Cell, 96, pp. 667-676; Gerlich, D., Beaudouin, J., Kalbfuss, B., Daigle, N., Eils, R., Ellenberg, J., Global chromosome positions are transmitted through mitosis in mammalian cells (2003) Cell, 112, pp. 751-764; Griffiths, A.D., Williams, S.C., Hartley, O., Isolation of high affinity human antibodies directly from large synthetic repertoires (1994) EMBO J, 13, pp. 3245-3260; Hakim, R., Benhar, I., Inclonals'': IgGs and IgG-enzyme fusion proteins produced in an e (2009) Coli Expression-refolding System. MAbs, 1, pp. 281-287; Hawlisch, H., Muller, M., Frank, R., Bautsch, W., Klos, A., Kohl, J., Site-specific anti-C3a receptor single-chain antibodies selected by differential panning on cellulose sheets (2001) Anal Biochem, 293, pp. 142-145; Herschhorn, A., Hizi, A., Virtual screening, identification, and biochemical characterization of novel inhibitors of the reverse transcriptase of human immunodeficiency virus type-1 (2008) J Med Chem, 51, pp. 5702-5713; Herschhorn, A., Marasco, W.A., Hizi, A., Antibodies and lentiviruses that specifically recognize a T cell epitope derived from HIV-1 Nef protein and rresented by HLA-C (2010) J Immunol, 185, pp. 7623-7632; Hoogenboom, H.R., Lutgerink, J.T., Pelsers, M.M., Selectiondominant and nonaccessible epitopes on cell-surface receptors revealed by cell-panning with a large phage antibody library (1999) Eur J Biochem, 260, pp. 774-784; Hoogenboom, H.R., Selecting and screening recombinant antibody libraries (2005) Nat Biotechnol, 23, pp. 1105-1116; Hust, M., Maiss, E., Jacobsen, H.J., Reinard, T., The production of a genus-specific recombinant antibody (scFv) using a recombinant potyvirus protease (2002) J Virol Methods, 106, pp. 225-233; Hutter, G., Neumann, M., Nowak, D., Klein, S., Kluter, H., Hofmann, W.K., The effect of the CCR5-delta32 deletion on global gene expression considering immune response and inflammation (2011) J Inflamm, 8, p. 29; Jacobson, J.M., Thompson, M.A., Lalezari, J.P., Anti-HIV-1 activity of weekly or biweekly treatment with subcutaneous PRO 140, a CCR5 monoclonal antibody (2010) J Infect Dis, 201, pp. 1481-1487; Jacobson, J.M., Lalezari, J.P., Thompson, M.A., Phase 2a study of the CCR5 monoclonal antibody PRO 140 administered intravenously to HIV-infected adults (2010) Antimicrob Agents Chemother, 54, pp. 4137-4142; Ji, C., Brandt, M., Dioszegi, M., Novel CCR5 monoclonal antibodies with potent and broad-spectrum anti-HIV activities (2007) Antiviral Res, 74, pp. 125-137; Kabir, M.E., Krishnaswamy, S., Miyamoto, M., Furuichi, Y., Komiyama, T., An improved phage-display panning method to produce an HM-1 killer toxin anti-idiotypic antibody (2009) BMC Biotechnol, 9, p. 99; Khurana, S., Kennedy, M., King, L.R., Golding, H., Identification of a linear peptide recognized by monoclonal antibody 2D7 capable of generating CCR5-specific antibodies with human immunodeficiency virus-neutralizing activity (2005) J Virol, 79, pp. 6791-6800; Krebs, B., Rauchenberger, R., Reiffert, S., High-throughput generation and engineering of recombinant human antibodies (2001) J Immunol Methods, 254, pp. 67-84; Lalezari, J., Thompson, M., Kumar, P., Antiviral activity and safety of 873140, a novel CCR5 antagonist, during shortterm monotherapy in HIV-infected adults (2005) AIDS, 19, pp. 1443-1448; Lanyi, J.K., Bacteriorhodopsin (1999) Int Rev Cytol, 187, pp. 161-202; Lee, B., Sharron, M., Blanpain, C., Epitope mapping of CCR5 reveals multiple conformational states and distinct but overlapping structures involved in chemokine and coreceptor function (1999) J Biol Chem, 274, pp. 9617-9626; Li, L., Sun, T., Yang, K., Zhang, P., Jia, W.Q., Monoclonal CCR5 antibody for treatment of people with HIV infection (2011) Cochrane Database Syst Rev, pp. CD008439; Lopalco, L., Natural anti-CCR5 antibodies in HIV-infection and-exposure (2011) J Transl Med, 9, pp. S4; Mack, M., Luckow, B., Nelson, P.J., Aminooxypentane-RANTES induces CCR5 internalization but inhibits recycling: A novel inhibitory mechanism of HIV infectivity (1998) J Exp Med, 187, pp. 1215-1224; Maeda, K., Nakata, H., Koh, Y., Spirodiketopiperazinebased CCR5 inhibitor which preserves CC-chemokine/ CCR5 interactions and exerts potent activity against R5 human immunodeficiency virus type 1 in vitro (2004) J Virol, 78, pp. 8654-8662; Malmborg, A.C., Duenas, M., Ohlin, M., Soderlind, E., Borrebaeck, C.A., Selection of binders from phage displayed antibody libraries using the BIAcore biosensor (2004) J Immunol Methods, 198, pp. 51-57; Marasco, W.A., Intrabodies as antiviral agents (2001) Curr Top Microbiol Immunol, 60, pp. 247-270; Marks, J.D., Hoogenboom, H.R., Bonnert, T.P., McCafferty, J., Griffiths, A.D., Winter, G., By-passing immunization human antibodies from v-gene libraries displayed on phage (1991) J Mol Biol, 222, pp. 581-597; Mirzabekov, T., Bannert, N., Farzan, M., Hofmann, W., Kolchinsky, P., Wu, L., Wyatt, R., Sodroski, J., Enhanced expression, native purification, and characterization of CCR5, a principal HIV-1 coreceptor (1999) J Biol Chem, 274, pp. 28745-28750; Mirzabekov, T., Kontos, H., Farzan, M., Marasco, W., Sodroski, J., Paramagnetic proteoliposomes containing a pure, native, and oriented seven-transmembrane segment protein, CCR5 (2000) Nat Biotechnol, 18, pp. 649-654; Nagata, S., Onda, M., Numata, Y., Santora, K., Beers, R., Kreitman, R.J., Pastan, I., Novel anti-CD30 recombinant immunotoxins containing disulfide-stabilized Fv fragments (2002) Clin Cancer Res, 8, pp. 2345-2355; Noppe, W., Plieva, F., Galaev, I.Y., Pottel, H., Deckmyn, H., Mattiasson, B., Chromato-panning: An efficient new mode of identifying suitable ligands from phage display libraries (2009) BMC Biotechnol, 9, p. 21; Olson, W.C., Rabut, G.E., Nagashima, K.A., Differential inhibition of human immunodeficiency virus type 1 fusion, gp120 binding, and CC-chemokine activity by monoclonal antibodies to CCR5 (1999) J Virol, 73, pp. 4145-4155; Olson, W.C., Jacobson, J.M., CCR5 monoclonal antibodies for HIV-1 therapy (2009) Curr Opin HIV AIDS, 4, pp. 104-111; Otto, M., Snejdarkova, M., A simple and rapid method for the quantitative isolation of proteins from polyacrylamide gels (1981) Anal Biochem, 111, pp. 111-114; Popkov, M., Rader, C., Barbas, C.F., Isolation of human prostate cancer cell reactive antibodies using phage display technology (2004) J Immunol Methods, 291, pp. 137-151; Strizki, J.M., Tremblay, C., Xu, S., Discovery and characterization of vicriviroc (SCH 417690), a CCR5 antagonist with potent activity against human immunodeficiency virus type (2005) Antimicrob Agents Chemother, 9, pp. 4911-4919; Tate, C.G., Grisshammer, R., Expression of gprotein-coupled receptors h (1996) Trends Biotechnol, 14, pp. 426-430; Teng, G., Papavasiliou, F.N., Immunoglobulin somatic hypermutation (2007) Annu Rev Genet, 41, pp. 107-120; Trkola, A., Ketas, T.J., Nagashima, K.A., Potent, broadspectrum inhibition of human immunodeficiency virus type 1 by the CCR5 monoclonal antibody PRO 140 (2001) J Virol, 75, pp. 579-588; Walter, G., Konthur, Z., Lehrach, H., High-throughput screening of surface displayed gene products (2001) Comb Chem High Throughput Screen, 4, pp. 193-205; Watson, C., Jenkinson, S., Kazmierski, W., Kenakin, T., The CCR5 receptor-based mechanism of action of 873140, a potent allosteric noncompetitive HIV entry inhibitor (2005) Mol Pharmacol, 67, pp. 1268-1282; Weber, K., Osborn, M., The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis (1969) J Biol Chem, 244, pp. 4406-4412; Wood, A., Armour, D., The discovery of the CCR5 receptor antagonist, UK-427,857, a new agent for the treatment of HIV infection and AIDS (2005) Prog Med Chem, 43, pp. 239-271; Zhang, J., Rao, E., Dioszegi, M., The second extracellular loop of CCR5 contains the dominant epitopes for highly potent anti-human immunodeficiency virus monoclonal antibodies (2007) Antimicrob Agents Chemother, 51, pp. 1386-1397
PY - 2013/8/1
Y1 - 2013/8/1
N2 - Selecting for antibodies against specific cell-surface proteins is a difficult task due to many unrelated proteins that are expressed on the cell surface. Here, we describe a method to screen antibody-presenting phage libraries against native cell-surface proteins. We applied this method to isolate antibodies that selectively recognize CCR5, which is the major co-receptor for HIV entry (consequently, playing a pivotal role in HIV transmission and pathogenesis). We employed a phage screening strategy by using cells that co-express GFP and CCR5, along with an excess of control cells that do not express these proteins (and are otherwise identical to the CCR5-expressing cells). These control cells are intended to remove most of the phages that bind the cells nonspecifically; thus leading to an enrichment of the phages presenting anti-CCR5-specific antibodies. Subsequently, the CCR5-presenting cells were quantitatively sorted by flow cytometry, and the bound phages were eluted, amplified, and used for further successive selection rounds. Several different clones of human single-chain Fv antibodies that interact with CCR5-expressing cells were identified. The most specific monoclonal antibody was converted to a full-length IgG and bound the second extracellular loop of CCR5. The experimental approach presented herein for screening for CCR5-specific antibodies can be applicable to screen antibody-presenting phage libraries against any cell-surface expressed protein of interest.
AB - Selecting for antibodies against specific cell-surface proteins is a difficult task due to many unrelated proteins that are expressed on the cell surface. Here, we describe a method to screen antibody-presenting phage libraries against native cell-surface proteins. We applied this method to isolate antibodies that selectively recognize CCR5, which is the major co-receptor for HIV entry (consequently, playing a pivotal role in HIV transmission and pathogenesis). We employed a phage screening strategy by using cells that co-express GFP and CCR5, along with an excess of control cells that do not express these proteins (and are otherwise identical to the CCR5-expressing cells). These control cells are intended to remove most of the phages that bind the cells nonspecifically; thus leading to an enrichment of the phages presenting anti-CCR5-specific antibodies. Subsequently, the CCR5-presenting cells were quantitatively sorted by flow cytometry, and the bound phages were eluted, amplified, and used for further successive selection rounds. Several different clones of human single-chain Fv antibodies that interact with CCR5-expressing cells were identified. The most specific monoclonal antibody was converted to a full-length IgG and bound the second extracellular loop of CCR5. The experimental approach presented herein for screening for CCR5-specific antibodies can be applicable to screen antibody-presenting phage libraries against any cell-surface expressed protein of interest.
UR - http://www.scopus.com/inward/record.url?scp=84882362137&partnerID=8YFLogxK
U2 - https://doi.org/10.1089/vim.2012.0029
DO - https://doi.org/10.1089/vim.2012.0029
M3 - مقالة
C2 - 23941674
SN - 0882-8245
VL - 26
SP - 277
EP - 290
JO - Viral Immunology
JF - Viral Immunology
IS - 4
ER -